Publication Title
J Immunother Cancer
Document Type
Article
Publication Date
1-1-2017
Keywords
Cancer Vaccines; Humans; Immunotherapy; Neoplasms; Tumor Microenvironment
Abstract
This report is a summary of 'New Cancer Immunotherapy Agents in Development' program, which took place in association with the 31st Annual Meeting of the Society for Immunotherapy of Cancer (SITC), on November 9, 2016 in National Harbor, Maryland. Presenters gave brief overviews of emerging clinical and pre-clinical immune-based agents and combinations, before participating in an extended panel discussion with multidisciplinary leaders, including members of the FDA, leading academic institutions and industrial drug developers, to consider topics relevant to the future of cancer immunotherapy.
Area of Special Interest
Cancer
Specialty/Research Institute
Oncology
